Literature DB >> 20136849

Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis.

J Broséus1, B Visomblain, J Guy, M Maynadié, F Girodon.   

Abstract

Hereditary spherocytosis (HS) is a common red blood cell disorder. It has been shown that the mean sphered corpuscular volume (MSCV), an artificial volume, is always lower than the MCV in HS and also in some autoimmune haemolytic anaemia (AIHA). Our purpose was to assess the reliability of MSCV in routine practise, and its relevance in screening for HS. Comparison of MSCV and MCV was undertaken in a prospective study of 366 patients with anaemia. In addition, included were patients previously diagnosed to have HS (n = 33) or AIHA (n = 16). When MSCV was lower than MCV, a flow cytometric (FC) test for HS was performed. Delta (MCV-MSCV) values >9.6 fl were obtained for all HS patients. A wider spread of delta (MCV-MSCV) values was obtained for AIHA patients whose red cells gave FC test results negative for HS. In the ROC curve analysis, the determination of delta (MCV-MSCV) value has a 90.57% specificity and 100% sensitivity for HS. MSCV is a reliable automated parameter indicating possible HS. When a delta (MCV-MSCV) value is >9.6 fl, the FC test and the Coombs test are required in the differential diagnosis of HS and some AIHA.

Entities:  

Mesh:

Year:  2010        PMID: 20136849     DOI: 10.1111/j.1751-553X.2009.01216.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  10 in total

1.  Flow cytometry test for hereditary spherocytosis.

Authors:  Géraud Mackiewicz; François Bailly; Bernardine Favre; Julien Guy; Marc Maynadié; François Girodon
Journal:  Haematologica       Date:  2012-12       Impact factor: 9.941

2.  Usefulness of Reticulocyte Parameters for Diagnosis of Hereditary Spherocytosis in Children.

Authors:  Olga Ciepiela; Anna Adamowicz-Salach; Andżelika Radgowska; Katarzyna Żbikowska; Iwona Kotuła
Journal:  Indian J Hematol Blood Transfus       Date:  2016-05-24       Impact factor: 0.900

Review 3.  Old and new insights into the diagnosis of hereditary spherocytosis.

Authors:  Olga Ciepiela
Journal:  Ann Transl Med       Date:  2018-09

4.  Mean corpuscular volume of control red blood cells determines the interpretation of eosin-5'-maleimide (EMA) test result in infants aged less than 6 months.

Authors:  Olga Ciepiela; Anna Adamowicz-Salach; Weronika Bystrzycka; Jan Łukasik; Iwona Kotuła
Journal:  Ann Hematol       Date:  2015-04-25       Impact factor: 3.673

5.  A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data.

Authors:  Jimin Kahng; Yonggoo Kim; Jung Ok Kim; Kwangsang Koh; Jong Wook Lee; Kyungja Han
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

6.  α-thalassaemia combined with hereditary spherocytosis in the same patient.

Authors:  Xiaohong Li; Lin Liao; Xuelian Deng; Jian Huang; Zengfu Deng; Hongying Wei; Wuning Mo; Faquan Lin
Journal:  Exp Ther Med       Date:  2017-11-28       Impact factor: 2.447

7.  Blood cell parameters for screening and diagnosis of hereditary spherocytosis.

Authors:  Lin Liao; Yuchan Xu; Hongying Wei; Yuling Qiu; Wenqiang Chen; Jian Huang; Yifeng Tao; Xuelian Deng; Zengfu Deng; Hui Tao; Faquan Lin
Journal:  J Clin Lab Anal       Date:  2019-04-03       Impact factor: 2.352

Review 8.  The diagnostic protocol for hereditary spherocytosis-2021 update.

Authors:  Yangyang Wu; Lin Liao; Faquan Lin
Journal:  J Clin Lab Anal       Date:  2021-10-24       Impact factor: 2.352

9.  Influence of diabetes and hypercholesterolemia on laboratory methods for hereditary spherocytosis diagnosis.

Authors:  Elena Lazarova; Béatrice Gulbis
Journal:  J Clin Lab Anal       Date:  2022-01-26       Impact factor: 2.352

10.  Acoustophoretic Orientation of Red Blood Cells for Diagnosis of Red Cell Health and Pathology.

Authors:  Laura G Rico; Jordi Juncà; Mike D Ward; Jolene A Bradford; Jorge Bardina; Jordi Petriz
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.